Cytomegalovirus Retinitis Clinical Trial
Official title:
A Clinical Study of High Concentration(2%) Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Clinical study of high concentration ganciclovir eye drops in the treatment of cytomegalovirus retinitis
Approval of the study was obtained from the hospital's ethical committee. The study design and methodology followed the tenets of Declaration of Helsinki. All patients were provided with written informed consent and received a thorough explanation of the use of 2% Ganciclovir Eye Drops, its potential risks and benefits. This is a monocencer, single arm, prospective study. The experimental group is: 2% Ganciclovir Eye Drops therapy group. Administration method and dose adjustment: 2% ganciclovir eye drops, 10 times / day for two weeks, 8 times/day for two weeks, 6 times/day for two weeks, 4 times/day for more than six weeks. According to best corrected visual acuity (BCVA), intraocular pressure, corneal abrasion, anterior chamber and vitreous inflammation, optical coherence tomography (OCT), Ultra wide angle fundus image and so on. The investigators evaluate the effects of 2% Ganciclovir Eye Drops in treatment of cytomegalovirus retinitis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00000135 -
Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
|
Phase 2/Phase 3 | |
| Completed |
NCT00000118 -
Ganciclovir Implant Study for Cytomegalovirus Retinitis
|
Phase 3 | |
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Completed |
NCT00000143 -
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
|
Phase 3 | |
| Completed |
NCT01866397 -
Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration
|
Phase 4 | |
| Completed |
NCT00004794 -
Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
|
Phase 2 | |
| Completed |
NCT00000136 -
Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
|
Phase 3 | |
| Completed |
NCT00091884 -
Efficacy of Elevated CD4 Counts on CMV Retinitis
|
N/A | |
| Completed |
NCT00002377 -
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
|
Phase 3 | |
| Completed |
NCT00001611 -
Immune Activity Against CVM Retinitis
|
N/A | |
| Completed |
NCT00000134 -
Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
|
Phase 3 | |
| Completed |
NCT00000168 -
Longitudinal Study of Ocular Complications of AIDS (LSOCA)
|
N/A | |
| Completed |
NCT04831333 -
Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis
|
||
| Active, not recruiting |
NCT00002301 -
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir
|
N/A | |
| Active, not recruiting |
NCT00002384 -
A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
|
N/A | |
| Active, not recruiting |
NCT00017784 -
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
|
Phase 3 | |
| Completed |
NCT00002321 -
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
|
Phase 1 | |
| Completed |
NCT00001061 -
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
|
Phase 2 | |
| Completed |
NCT00002025 -
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
|
N/A | |
| Completed |
NCT00002070 -
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
|
Phase 3 |